During a White House lunch, President Donald Trump urged Republican Senators to pass a “generous” replacement program for the Patient Protection and Affordable Care Act (PPACA), according to a Reuters report.
Seriously ill patients on breathing machines can have their chances for survival increased from 60% to 70% if the machines are programmed to deliver enough life-sustaining breaths, but not so much that it damages lungs by overinflating them.
A study examining the impact of antibiotics prescribed for nearly 1,500 adult patients admitted to the Johns Hopkins Hospital has found that adverse events occurred in a fifth of them, and that nearly a fifth of those effects occurred in patients who didn’t need antibiotics in the first place.
Researchers at the National Institutes of Health’s National Center for Advancing Translational Sciences (NCATS) and at the University of Nevada Reno School of Medicine (UNR Med) have demonstrated that a drug originally targeted unsuccessfully to treat cancer may have new life as a potential treatment for patients with Duchenne muscular dystrophy (DMD).
From May 2011 through June 2014, the Centers for Medicare and Medicaid Services (CMS) paid an estimated $729 million in Medicare electronic health record (EHR) incentive payments to eligible professionals (EPs) who did not comply with federal requirements, according to an audit conducted by the Department of Heath and Human Services Office of Inspector Ge
While politicians squabble over how to dismantle the Patient Protection and Affordable Care Act (PPACA), the country is suffering from a bad case of health care insecurity, according to a survey posted on the Bankrate website.
A group of doctors and administrators has come up with an ambitious plan for Colorado hospitals to reduce the amount of opioids they prescribe while still treating pain effectively, according to an article in the Denver Post. The plan will roll out this year as a six-month pilot program at eight hospitals and three freestanding emergency rooms.
In a study involving simulated out-of-hospital cardiac arrests (OHCAs), drones carrying an automated external defibrillator (AED) arrived in less time than emergency medical service (EMS) ambulances, with a reduction in response time of approximately 16 minutes, according to a new study published in JAMA.
An international phase 3 trial of Bronchitol (mannitol, Pharmaxis Ltd.) in adults with cystic fibrosis (CF) has met its primary endpoint. The study was designed to gain marketing approval of Bronchitol in the United States. An FDA submission is expected in 2018.
As if Senate GOP leaders need more problems in attempting to dismantle the Patient Protection and Affordable Care Act (PPACA), the nation’s worsening opioid crisis threatens to throw another monkey wrench into their plans.
In a pivotal ruling, the Supreme Court has cut the time it will take for copycat versions of biologic drugs to reach the marketplace, according to a Reuters report. The decision could yield billions of dollars in sales for drug companies.
The FDA has issued a complete response letter (CRL) with regard to a biologics license application for CHS-1701, a biosimilar candidate for pegfilgrastim (Neulasta, Amgen) developed by Coherus BioSciences.